<http://www.wikidata.org/entity/statement/Q65355356-24770E15-9CE2-4EBB-ADB2-4A4E57556536>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q65355356-24770E15-9CE2-4EBB-ADB2-4A4E57556536>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .
<http://www.wikidata.org/entity/statement/Q65355356-24770E15-9CE2-4EBB-ADB2-4A4E57556536>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .
<http://www.wikidata.org/entity/statement/Q65355356-24770E15-9CE2-4EBB-ADB2-4A4E57556536>	<http://www.wikidata.org/prop/statement/P1476>	"Randomized Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer"@en .